Gladstone NOW: The Campaign Join Us on the Journey✕
241 - 255 of 339 Results Clear All
The Mercury News—Nevan Krogan explains his team’s approach to finding drugs to confront the COVID-19 pandemic: hunting for drugs that target the human proteins on which the virus relies.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
NBC Bay Area—Senior Investigator Nevan Krogan describes his team’s effort to identify drugs that disrupt the interactions between human cells and SARS-CoV-2, the virus that causes COVID-19.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
KQED—Gladstone Senior Investigator Nevan Krogan and his team found that many drugs already approved by the FDA for other purposes may be useful to treat COVID-19. The research also reveals that an ingredient commonly found in cough suppressants can cause the SARS-CoV-2 virus to grow more quickly in the lab setting.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
Engineering.com—Gladstone Senior Investigators Melanie Ott and Jennifer Doudna are collaborating with scientists across the Bay Area to develop a rapid COVID-19 testing platform that pairs CRISPR technology with a smartphone camera.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing
There are thousands of prescription drugs already approved by the FDA for treating diseases. Can one of them work for COVID-19?
Gladstone Experts Bioinformatics Core COVID-19 Center for HIV Cure Research Virology Greene Lab Krogan Lab
The Scientist—The COVID-19 pandemic has shuttered labs and made international travel almost impossible. Sudha Krishnamurthy, director of the Office of Postdoctoral and Graduate Student Affairs, explains that these changes, in combination with federal policies that have placed restrictions on immigration, will decrease the number of scientists who come to the US for training.
Postdoctoral and Graduate Student Education and Research Development Affairs Gladstone Experts Graduate Students and Postdocs
Medium—Amidst reports that some individuals who were thought to have recovered from COVID-19 later tested positive, scientists are investigating whether infection confers a lasting immunity. Gladstone Senior Investigator Warner Greene explains how little is known about this novel virus and how the human immune system responds to it.
Gladstone Experts COVID-19 Virology Greene Lab
Medium—Amidst reports that some individuals who were thought to have recovered from COVID-19 later tested positive, scientists are investigating whether infection confers a lasting immunity. Gladstone Senior Investigator Warner Greene explains how little is known about this novel virus and how the human immune system responds to it.
Gladstone Experts COVID-19 Virology Greene Lab
Karma Impact—COVID-19 poses a threat to humanity that will require significant scientific innovation to overcome. Gladstone President Deepak Srivastava explains that early investment in biomedical research is necessary to find new therapies.
Gladstone Experts COVID-19
MEDPAGE Today—It’s not yet known if the presence of antibodies to SARS-CoV-2, the virus that causes COVID-19, will confer a lasting immunity to the disease. Gladstone Senior Investigator Warner Greene explains that people who had been infected with the related SARS virus showed immunity for up to 6 years, providing some hope that a similar response may protect individuals from repeated COVID-19 infections.
Gladstone Experts COVID-19 Virology Greene Lab
San Francisco Chronicle—New research in California shows that young and middle-aged adults may be as vulnerable to COVID-19 as senior citizens are. Gladstone Senior Investigator Warner Greene explains that this finding differs from earlier studies in Italy and China.
Gladstone Experts COVID-19 Greene Lab
KRON4—Gladstone Senior Investigator Warner Greene explains that the scientific community is hard at work trying to identify therapies to treat COVID-19, and warns that disinfectants are poisonous and should not be ingested.
Gladstone Experts COVID-19 Virology Greene Lab
Researchers who spent decades studying human immunodeficiency virus are using some of the same tools and approaches to tackle SARS-CoV-2, the virus that causes COVID-19.
Gladstone Experts COVID-19 HIV/AIDS Center for HIV Cure Research Virology Akassoglou Lab Doudna Lab Greene Lab Ott Lab
Many Gladstone researchers rely on computational approaches, machine learning, and innovative software to make biomedical discoveries.
Gladstone Experts Bioinformatics Core HIV/AIDS Zika Virus Center for HIV Cure Research Center for Systems and Therapeutics Data Science and Biotechnology Neurological Disease Virology Finkbeiner Lab
Warner Greene, MD, PhD, brings his expertise in the field of virology to share insight on SARS-CoV-2 and the COVID-19 pandemic.
Gladstone Experts COVID-19 Greene Lab
